Sofinnova Partners

Investor type

VC

Founded

1972

AUM

$4 320 M

Location

Paris, France

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A, Series B

Investment Stage

IPO, Mergers and Aquisitions, MBO, Private Sales

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.

Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €4 billion under management. For more information, please visit: www.sofinnovapartners.com

Industry

Agriculture Biotechnology Digital Food and Beverage Healthcare Services Medical Devices MedTech HealthTech SaaS Software Life Sciences Energy Foodtech

Region of investment

North America Europe

Sofinnova Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Sofinnova Biovelocita II
Venture Capital (VC)
Biotechnology
Healthcare Services
Pre-seed
Seed
Europe
$5-10 m
$181 M
March 2025
Life Science
Venture Capital (VC)
MedTech
Pre-seed
Seed
Europe
$5-10 m
$1296 M
March 2025
Sofinnova Digital Medicine I
Venture Capital (VC)
Biotechnology
Digital
Healthcare Services
Pre-seed
Seed
Europe
$5-10 m
$200 M
October 2023
Sofinnova Capital XI
Venture Capital (VC)
Healthcare Services
SaaS
Software
Life Sciences
Energy
HealthTech
Seed
North America
Europe
$5-10 m
$750 M
November 2025
Sofinnova Biovelocita II
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
Life Sciences
Energy
HealthTech
Seed
North America
Europe
$5-10 m
$170 M
March 2025

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
2lKY4NCVkGpuZ1E6 2lKY4NCVkGpuZ1E6
2lKY4NCVkGpuZ1E6
avatar
2lKY4NCVkGpuZ1E6 2lKY4NCVkGpuZ1E6
2lKY4NCVkGpuZ1E6
avatar
2lKY4NCVkGpuZ1E6 2lKY4NCVkGpuZ1E6
2lKY4NCVkGpuZ1E6
avatar
2lKY4NCVkGpuZ1E6 2lKY4NCVkGpuZ1E6
2lKY4NCVkGpuZ1E6
avatar
2lKY4NCVkGpuZ1E6 2lKY4NCVkGpuZ1E6
2lKY4NCVkGpuZ1E6
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Sofinnova Partners

Sofinnova Partners is located in Paris, France.
Sofinnova Partners was founded in 1972.
Sofinnova Partners invests in companies and startups in Agriculture, Biotechnology, Digital, Food and Beverage, Healthcare Services, Medical Devices, MedTech, HealthTech, SaaS, Software, Life Sciences, Energy, Foodtech.
Sofinnova Partners invests in companies and startups in North America, Europe.
Sofinnova Partners invests in companies and startups at Seed, Series A, Series B.
Sofinnova Partners usually invests $10-50 m on average.
Sofinnova Partners has around $4 320m assets under management.
Sofinnova Partners last fund was created/launched in 2025-11-17